Invasive Meningococcal Disease (IMD) is a serious bacterial illness with a high case fatality ratio, even with the advancements of modern medicine.  At-risk populations include adolescents living on campus, along with international travellers heading to the Haj/Umrah Pilgrimage in Saudi Arabia, and the African "Meningitis Belt".    Learn about the currently available vaccination options to prevent IMD, including serogroup coverage, mechanism of action, and technical details of administration .  This presentation features an interactive case-based learning program powered by generative-AI to support application to pharmacy practice.  

Sponsored by Sanofi